Skip to content

Thryv Holdings, Inc. THRY Concentration Risk %

Concentration Risk % at other companies

Identive logo
IdentiveINVE
10.3%+7.7pp
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
RF Industries logo
RF IndustriesRFIL
100%0.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp

Segments

By geography

See full
International15.3%-3.2%

Other financials

Income statement

See full
Revenue$167.7M-7.5%
Gross profit$109.3M-8.4%
Operating income$4.1M+234%
Net income$4.5M+147%
EPS (diluted)$0.10+145%

Balance sheet

See full
Cash & equivalents$8.0M-27.7%
Total debt$26.3M0.0%
Total equity$225.4M+16.7%
Total assets$693.7M-1.4%

Cash flow

See full
Operating cash flow$1.5M+114%
CapEx$6.9M-2.2%
Free cash flow-$5.5M+69.0%

Valuation

See full
Market cap$174.74M-66.8%
Enterprise value$193.04M-63.1%
P/E12×+3.7×
P/S0.2×-0.5×

Profitability

See full
Gross margin67.8%+2.6pp
Operating margin8.3%+5.5pp
Net margin-38.9%
FCF margin5.6%+0.4pp

Returns & leverage

See full
Return on equity-138.2%
Debt / equity0.1×0.0×
Current ratio1.2×+0.2×